These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

475 related articles for article (PubMed ID: 29489077)

  • 1. Inflammation and Improvement of Depression Following Electroconvulsive Therapy in Treatment-Resistant Depression.
    Kruse JL; Congdon E; Olmstead R; Njau S; Breen EC; Narr KL; Espinoza R; Irwin MR
    J Clin Psychiatry; 2018; 79(2):. PubMed ID: 29489077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammation and remission in older patients with depression treated with electroconvulsive therapy; findings from the MODECT study
    Carlier A; Berkhof JG; Rozing M; Bouckaert F; Sienaert P; Eikelenboom P; Veerhuis R; Vandenbulcke M; Berkhof J; Stek ML; Rhebergen D; Dols A; Exel EV
    J Affect Disord; 2019 Sep; 256():509-516. PubMed ID: 31279250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ketamine vs Electroconvulsive Therapy for Treatment-Resistant Depression: A Secondary Analysis of a Randomized Clinical Trial.
    Jha MK; Wilkinson ST; Krishnan K; Collins KA; Sanacora G; Murrough J; Goes F; Altinay M; Aloysi A; Asghar-Ali A; Barnett B; Chang L; Costi S; Malone D; Nikayin S; Nissen SE; Ostroff R; Reti I; Wolski K; Wang D; Hu B; Mathew SJ; Anand A
    JAMA Netw Open; 2024 Jun; 7(6):e2417786. PubMed ID: 38916891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in interleukin-6 levels during electroconvulsive therapy may reflect the therapeutic response in major depression.
    Järventausta K; Sorri A; Kampman O; Björkqvist M; Tuohimaa K; Hämäläinen M; Moilanen E; Leinonen E; Peltola J; Lehtimäki K
    Acta Psychiatr Scand; 2017 Jan; 135(1):87-92. PubMed ID: 27858966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alteration of immune markers in a group of melancholic depressed patients and their response to electroconvulsive therapy.
    Rush G; O'Donovan A; Nagle L; Conway C; McCrohan A; O'Farrelly C; Lucey JV; Malone KM
    J Affect Disord; 2016 Nov; 205():60-68. PubMed ID: 27414954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Maudsley Staging Method as predictor of electroconvulsive therapy effectiveness in depression.
    van Diermen L; Hebbrecht K; Schrijvers D; Sabbe BCG; Fransen E; Birkenhäger TK
    Acta Psychiatr Scand; 2018 Dec; 138(6):605-614. PubMed ID: 30270433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low tumor necrosis factor-α levels predict symptom reduction during electroconvulsive therapy in major depressive disorder.
    Sorri A; Järventausta K; Kampman O; Lehtimäki K; Björkqvist M; Tuohimaa K; Hämäläinen M; Moilanen E; Leinonen E
    Brain Behav; 2018 Apr; 8(4):e00933. PubMed ID: 29670819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antidepressant efficacy of electroconvulsive therapy is associated with a reduction of the innate cellular immune activity in the cerebrospinal fluid in patients with depression.
    Kranaster L; Hoyer C; Aksay SS; Bumb JM; Müller N; Zill P; Schwarz MJ; Sartorius A
    World J Biol Psychiatry; 2018 Aug; 19(5):379-389. PubMed ID: 28714751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes of cytokine profiles during electroconvulsive therapy in patients with major depression.
    Rotter A; Biermann T; Stark C; Decker A; Demling J; Zimmermann R; Sperling W; Kornhuber J; Henkel A
    J ECT; 2013 Sep; 29(3):162-9. PubMed ID: 23609520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing the Association Between Electrical Stimulation Dose, Subsequent Cognitive Function and Depression Severity in Patients Receiving Bilateral Electroconvulsive Therapy for Major Depressive Disorder.
    Sinclair JE; Fernie G; Bennett DM; Reid IC; Cameron IM
    J ECT; 2016 Sep; 32(3):159-63. PubMed ID: 27128722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Depressive Symptom Dimensions in Treatment-Resistant Major Depression and Their Modulation With Electroconvulsive Therapy.
    Wade BSC; Hellemann G; Espinoza RT; Woods RP; Joshi SH; Redlich R; Jørgensen A; Abbott CC; Oedegaard KJ; McClintock SM; Oltedal L; Narr KL
    J ECT; 2020 Jun; 36(2):123-129. PubMed ID: 31464814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammation, Hippocampal Volume, and Therapeutic Outcome following Electroconvulsive Therapy in Depressive Patients: A Pilot Study.
    Belge JB; van Diermen L; Sabbe B; Parizel P; Morrens M; Coppens V; Constant E; de Timary P; Sienaert P; Schrijvers D; van Eijndhoven P
    Neuropsychobiology; 2020; 79(3):222-232. PubMed ID: 32114575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Executive function in treatment-resistant depression before and after electroconvulsive therapy.
    Stojanovic Z; Andric S; Soldatovic I; Dolic M; Spiric Z; Maric NP
    World J Biol Psychiatry; 2017 Dec; 18(8):624-632. PubMed ID: 27072874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammation and Cognitive Functioning in Depressed Older Adults Treated With Electroconvulsive Therapy: A Prospective Cohort Study.
    Carlier A; Rhebergen D; Veerhuis R; Schouws S; Oudega ML; Eikelenboom P; Bouckaert F; Sienaert P; Obbels J; Stek ML; van Exel E; Dols A
    J Clin Psychiatry; 2021 Aug; 82(5):. PubMed ID: 34383393
    [No Abstract]   [Full Text] [Related]  

  • 15. Inflammation and depression treatment response to electroconvulsive therapy: Sex-specific role of interleukin-8.
    Kruse JL; Olmstead R; Hellemann G; Wade B; Jiang J; Vasavada MM; Brooks Iii JO; Congdon E; Espinoza R; Narr KL; Irwin MR
    Brain Behav Immun; 2020 Oct; 89():59-66. PubMed ID: 32479994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokines changes associated with electroconvulsive therapy in patients with treatment-resistant depression: a Meta-analysis.
    Gay F; Romeo B; Martelli C; Benyamina A; Hamdani N
    Psychiatry Res; 2021 Mar; 297():113735. PubMed ID: 33497973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RETRACTED: Electroconvulsive therapy and aerobic exercise training increased BDNF and ameliorated depressive symptoms in patients suffering from treatment-resistant major depressive disorder.
    Salehi I; Hosseini SM; Haghighi M; Jahangard L; Bajoghli H; Gerber M; Pühse U; Kirov R; Holsboer-Trachsler E; Brand S
    J Psychiatr Res; 2014 Oct; 57():117-24. PubMed ID: 25073431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. S100B, Homocysteine, Vitamin B12, Folic Acid, and Procalcitonin Serum Levels in Remitters to Electroconvulsive Therapy: A Pilot Study.
    Maier H; Helm S; Toto S; Moschny N; Sperling W; Hillemacher T; Kahl KG; Jakubovski E; Bleich S; Frieling H; Neyazi A
    Dis Markers; 2018; 2018():2358451. PubMed ID: 29545905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between baseline serum vascular endothelial growth factor levels and response to electroconvulsive therapy.
    Minelli A; Maffioletti E; Bortolomasi M; Conca A; Zanardini R; Rillosi L; Abate M; Giacopuzzi M; Maina G; Gennarelli M; Bocchio-Chiavetto L
    Acta Psychiatr Scand; 2014 Jun; 129(6):461-6. PubMed ID: 23957507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electroconvulsive Therapy Versus Repetitive Transcranial Magnetic Stimulation in Patients With a Depressive Episode: A Register-Based Study.
    Strandberg P; Nordenskjöld A; Bodén R; Ekman CJ; Lundberg J; Popiolek K
    J ECT; 2024 Jun; 40(2):88-95. PubMed ID: 38048154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.